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Abstract. Milk production during lactation is a conse- 
quence of the suckling stimulus and the presence of glu- 
cocorticoids, prolactin, and insulin. After weaning the 
glucocorticoid hormone level drops, secretory mam- 
mary epithelial cells die by programmed cell death and 
the gland is prepared for a new pregnancy. We studied 
the role of steroid hormones and prolactin on the mam- 
mary gland structure, milk protein synthesis, and on 
programmed cell death. Slow-release plastic pellets 
containing individual hormones were implanted into a 
single mammary gland at lactation. At the same time 
the pups were removed and the consequences of the re- 
lease of hormones were investigated histologically and 
biochemically. We found a local inhibition of involution 
in the vicinity of deoxycorticosterone- and progester- 
one-release pellets while prolactin-release pellets were 
ineffective. Dexamethasone, a very stable and potent 
glucocorticoid hormone analogue, inhibited involution 
and programmed cell death in all the mammary glands. 
It led to an accumulation of milk in the glands and was 
accompanied by an induction of protein kinase A, AP-1 
DNA binding activity and elevated c-los, ]unB, and 
junD mRNA levels. Several potential target genes of 
AP-1 such as stromelysin-1, c-]un, and SGP-2 that are 
induced during normal involution were strongly inhib- 
ited in dexamethasone-treated animals. Our results 
suggest that the cross-talk between steroid hormone re- 
ceptors and AP-1 previously described in cells in cul- 
ture leads to an impairment of AP-1 activity and to an 
inhibition of involution in the mammary gland implying 
that programmed cell death in the postlactational mam- 
mary gland depends on functional AP-1. 
EVELOPMENT of the mammary gland is characterized 
by distinct phases of cellular proliferation during 
puberty and pregnancy, differentiation of epithe- 
lial cells in late pregnancy and extensive cell death and tis- 
sue remodeling during postlactational involution. It was 
shown that during involution the majority of secretory epi- 
thelial cells but also myoepithelial cells die by apoptosis, a 
form of programmed cell death (PCD) 1, (Walker et al., 
1989; Strange et al., 1992; Bielke et al., 1995). The phases 
of mammary epithelial cell proliferation and differentia- 
tion were shown to be under stringent hormonal control 
(Topper and Freeman, 1980). In culture, insulin, prolactin, 
and  hydrocortisone are  able  to  maintain mammary ex- 
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plants in a state of lactation (Topper et al., 1975). Further- 
more, these three hormones were shown to be sufficient to 
induce differentiation of established mammary epithelial 
cells in vitro (Danielson et al., 1984; Doppler et al., 1989; 
Reichmann et  al.,  1989).  That  some of these  hormones 
also have a critical function in the maintenance of lacta- 
tion in vivo is substantiated by the observation that hydro- 
cortisone  (Johnson  and  Meites,  1958; Ossowski  et  al., 
1979) and prolactin (Ossowski et al., 1979) inhibited mam- 
mary gland regression when injected at high doses into ro- 
dents. The mechanism by which these hormones inhibit in- 
volution is  not known  and it was  not clear from these 
studies whether prolactin and hydrocortisone act directly 
or indirectly on mammary cells in vivo. AP-1 is a heteroge- 
neous transcription factor consisting of a dimeric complex 
of members of the Fos, Jun, and ATF/CREB families of 
proteins  (Benbrook  and Jones,  1990; Angel and  Karin, 
1991;  Hai  and Curran,  1991).  Recently, we  have shown 
that AP-1 is induced during involution of the mouse mam- 
mary gland (Marti et al., 1994a). Members of AP-1 such as 
c-Fos  and JunD  are  expressed  in the  epithelium where 
they may act as potential regulators of epithelial cell death 
(Marti et al.,  1995).  Indeed, several genes have been re- 
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potential target genes of AP-1.  Among those  genes are 
sulfated glycoprotein (SGP-2) (Strange et al., 1992), plas- 
minogen activator (Ossowski et al.,  1979), stromelysin-1 
(McDonnell et al., 1990; Kerr et al.,  1992; Strange et al., 
1992), and c-jun (Marti et al.,  1994a). In addition, several 
reports demonstrate an involvement of c-Fos (Colotta et 
al., 1992; Smeyne et al., 1993) or c-Jun (Colotta et al., 1992; 
Estus et al., 1994) in the regulation of apoptosis of lym- 
phocytes, fibroblasts, or nerve cells in culture. We and oth- 
ers have described a complex cross-talk between AP-1 and 
several members of the steroid receptor superfamily (Jonat 
et al., 1990; Lucibello et al., 1990; Schtile et al., 1990; Yang- 
Yen et al., 1990; Shemshedini et al., 1991; Touray et al., 
1991a,b; Marti et al., 1994b). In these studies it was shown 
that ligand activated glucocorticoid receptor impairs c-Fos 
and c-Jun activity by a mechanism that probably involves a 
direct protein/protein interaction (Jonat et al., 1990; Tou- 
ray  et  al.,  1991a).  Other  steroids  such  as  retinoic  acid 
(Schtile et al., 1991; Fanjul et al., 1994; Herrlich and Ponta, 
1994)  and progesterone (Shemshedini et al.,  1991)  were 
shown to similarly impair the activity of c-Fos and c-Jun 
(in  the  case  of retinoic  acid)  or  c-Jun  (in  the  case  of 
progesterone). The cross-talk between the glucocorticoid 
receptor and AP-1 is mutual in that c-Fos, c-Jun, and JunD 
are  blocked  by ligand  activated  glucocorticoid receptor 
and,  vice  versa,  glucocorticoid receptor  function  is  im- 
paired by overexpressed c-Fos and c-Jun (but not JunD) 
(Schtile et al., 1990; Yang-Yen et al., 1990; Touray et al., 
1991a;  Berko-Flint et al., 1994; Marti et al., 1994b). Most 
of these studies were carried out with cells in culture and 
only a limited number of reports exists that describes this 
cross-talk in vivo (Herrlich and Ponta, 1994);  e.g., tumor 
promotion in the mouse skin that is dependent on a con- 
tinuous  stimulation  of AP-1  function by phorbol  esters 
was shown to be strongly inhibited by dexamethasone or 
retinoic acid (Belman and Troll, 1972; Verma, 1987). Fur- 
thermore, the response of embryonal retina glial cells to- 
wards cortisol was shown to be blocked by phorbol esters 
(Berko-Flint et  al.,  1994).  In  this  study we  demonstrate 
that  glucocorticoid  and  progesterone  inhibit  mammary 
gland involution by a local effect and we show that AP-1 is 
a potential target of this glucocorticoid hormone-mediated 
inhibition. We provide evidence that an absence of PCD 
of epithelial cells coincides with an inhibition of expression 
of several potential AP-l-dependent target genes includ- 
ing stromelysin-1, SGP-2, and c-jun. 
Material and Methods 
Preparation of Implants 
Dexamethasone, deoxycorticosterone acetate,  and progesterone (Sigma 
Chem. Co., St. Louis, MO) were dissolved in 70% ethanol and prolactin 
(Sigma) was dissolved in water. Steroid hormones and prolactin solutions 
were mixed with BSA and lyophilized. 10% Elvax dissolved in methylene 
chloride was added and the mixture was again lyophilized. Pellets were 
cut to a size of ~1.0 rag. One pellet contained 0.5 mg BSA in combination 
with 60 p.g steroid hormones or 50 I-Lg  prolactin. Control pellets contained 
0.5 mg BSA. 
Manipulation of  Animals and Implantation of 
Elvax Pellets 
Tissue was prepared from the fourth inguinal mammary gland of MORO 
mice. Involution was induced after 5 d of lactation by removing the pups. 
Lactating animals were anesthesized by intraperitoneal injection of Nem- 
butal (50  p.g/g body weight) and Elvax pellets containing deoxycortico- 
sterone acetate, progesterone, dexamethasone, prolactin, dexamethasone 
plus prolactin or BSA alone were implanted into one of the fourth in- 
guinal mammary glands by cutting a small pocket with an iris scissors. Im- 
planted and matched glands were analyzed 2, 3, or 4 d later. Blood was 
collected from the carotid arteria of anesthesized animals and analyzed for 
serum glucocorticoid levels. 
Histological Analysis and Terminal 
Transferase Reaction 
Tissue samples were fixed in freshly prepared 4% formaldehyde in phos- 
phate-buffered saline (50 mM KH2PO4, 150 mM NaC1,  pH 7.4), embed- 
ded in paraffin and 5-~m thick sections were stained with hematoxylin 
and eosin. For the terminal transferase reaction the procedure of Gavrieli 
et al. (1992) was employed with several modifications. Sections were treated 
with proteinase K  (10  ng/ml) for  15  min at  25°C.  Digoxigenin-labeled 
dUTP (Boehringer Mannheim Corp., Indianapolis, IN) was incorporated 
in the terminal transferase reaction and subsequently detected using fluo- 
rescein-coupled Fab fragments (Boehringer Mannheim Corp.). 
DNA Fragmentation Analysis 
DNA fragmentation was analyzed as described (Ishida et al., 1992)  with 
several modifications. 10-20 mg tissue was collected in cold PBS, homoge- 
nized with a polytron and incubated for 15 m  on ice in 10 mM Tris-HC1 
(pH 7.5), 10 mM EDTA, and 0.2% Triton X-100. The lysate was centri- 
fuged and the supernatant that contained RNA and small DNA fragments 
(but not intact chromatin) was extracted once with phenol and once with 
phenol/chloroform. The aqueous phase was adjusted to 300 mM NaCI and 
precipitated in 2 vol of ethanol. The nucleic acid was pelleted, air dried 
and dissolved in 10 mM Tris-HC1 (pH 7.5) and I mM EDTA. After RNase 
A treatment 20 Ixg DNA was electrophoresed in a 1.5% agarose gel with 
Boyer's buffer (50 mM Tris-HCl, pH 8, 20 mM NaAc, 2 mM EDTA, 18 
mM NaC1) containing ethidium bromide and visualized on an UV transil- 
luminator. 
RNA Analysis 
Total  RNA was  prepared  using guanidinium thiocyanate  as  described 
(Chomczynski and Sacchi,  1987).  10  ~.g total or 5  p.g poly(A)-selected 
RNA  were  separated  electrophoretically,  transferred to  nitrocellulose, 
and probed with random-prime labeled cDNA fragments corresponding 
to homologous sequences. Total RNA was used to probe for WAP and 
SGP-2 expression, and poly(A)-selected RNA to probe for c-los, c-jun, 
junB, junD, stromelysin-1, TIMP-1, and actin expression. 
Nuclear Extract Preparation,  PKA Assay, and DNA 
Bandshift Analysis 
Nuclear extracts were prepared  as described  (Marti et al.,  1994a).  For 
PKA assays 5 ixg extract was incubated with a fluorescent peptide (Kemp- 
tide; Promega Corp., Madison, WI) following the instructions of the man- 
ufacturer.  Phosphorylated  peptide  was  separated  from nonphosphory- 
luted peptide  by  agarose gel electrophoresis and visualized on an UV 
transilluminator. 
Figure 1.  Local  inhibition  of involution  and  PCD  ,by  deoxycorticosterone  acetate  and  progesterone.  Deoxycorticosterone  acetate- 
release pellets (a) or progesterone-release pellets (b) were implanted at lactation, the pups were removed and the glands were analyzed 
3 d  later. The upper panels show an overview of a  hematoxylin/eosin stained section adjacent to the implanted pellet  (P).  The lower 
panels show the indicated areas after terminal transferase assay reactions of serial sections at higher magnification. Bar, 100 Ixm. 
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(Marti et al., 1994a). a2p-labeled double-stranded oligonucleotides specific 
for AP-1 (5' AAGCATGAGTCAGACAC 3') was incubated with nuclear 
extract (5 ~,g) in a final volume of 25 ILl 5 mM MgCI2, 0.1 mM EDTA, 0.75 
mM DTr, 7.5% glycerol, 0.05%  NP-40, 3 ~g BSA, 2 Izg poly d(I-C) for 20 
min in the presence of protease inhibitors (Marti et al., 1994a). Complexes 
were resolved on a 6% polyacrylamide gel using 0.25 × TBE as buffer. 
Results 
A Drop in the Level of Glucocorticoid Hormone Is 
Essential for Mouse Mammary Gland Involution and 
Programmed Cell Death of Epithelial  Cells 
Glucocorticoid hormones are essential for lobular and al- 
veolar  development  during  pregnancy  and  milk  protein 
synthesis during lactation. We determined the level of glu- 
cocorticoid hormones at lactation and after 3 d of involu- 
tion in the serum of circulating blood and found a signifi- 
cant  drop  from 34  to  14  nmol per  liter  (p  <  1%).  We 
investigated whether an artificial elevation of glucocorti- 
coid hormone levels is sufficient to maintain the  lobulo- 
alveolar structure  of the  gland  and  to  prevent  PCD  of 
secretory epithelial cells (Fig.  1 a). Deoxycorticosterone- 
releasing plastic pellets were implanted into the fourth in- 
guinal mammary gland of a lactating animal and the pups 
were removed at the same time. The animals were killed 3 d 
later and the glands were analyzed histologically and with 
respect to DNA fragmentation by in situ terminal trans- 
ferase assay. A  partial preservation of the lobulo-alveolar 
structure was maintained in the close vicinity of the pellet 
and a normal alveolar regression and enlargement of adi- 
pocytes was observed more distantly to the implanted pel- 
let (Fig. 1 a, top) or in the contralateral gland of the same 
animal (data not shown). A terminal transferase assay was 
performed from sections prepared from tissue close to the 
pellet.  Fig.  1 a (bottom)  shows  that epithelial cells were 
predominantly negative around the pellet (left) whereas a 
majority of epithelial cells in alveoli located more distant 
to the pellet stained positive (right). These results imply 
that involution and DNA fragmentation is inhibited by a 
local release of glucocorticoid hormones and that the ef- 
fect is independent of the involvement of systemic effects 
in the animal. 
Progesterone Inhibits Involution and Programmed Cell 
Death in the Mammary Gland 
Glucocorticoid  hormones  are  important  for the  mainte- 
nance of milk protein synthesis during lactation. It is there- 
fore possible that the inhibition of involution and PCD in 
the area of the glucocorticoid-release pellets is due to the 
maintenance of a terminally differentiated state of secre- 
tory epithelial cells rather than an active inhibition of the 
cell  death  process. To further  define  the  mechanism by 
which glucocorticoids inhibit involution and PCD, the ef- 
fect of additional steroid hormones on the involution pro- 
cess was studied. Progesterone exerts its action by binding 
to the progesterone receptor. It is mainly promoting pro- 
liferation during pregnancy and has no essential function 
on  milk protein  synthesis  during  lactation  (Friesen  and 
Cowden,  1989).  Progesterone-release  pellets  were  im- 
planted into the mammary gland of lactating animals and 
the pups were removed. 3 d postoperation the implanted 
mammary glands were analyzed histologically and by in 
situ  terminal  transferase  assay.  Fig.  1  b  demonstrates  a 
partial preservation of the alveolar structure (top) and an 
absence of labeled nuclei after terminal transferase reac- 
tion in the vicinity of the pellet (bottom, left). More dis- 
tantly,  the  gland  was  morphologically  indistinguishable 
from a mammary gland during involution and most epithe- 
lial cells in these alveolar structures were positive in a ter- 
minal transferase  reaction  (right). These  results  demon- 
strate that progesterone and glucocorticoid similarly prevent 
involution and PCD in the vicinity of the pellets but not in 
areas more distant to the pellets. 
Inhibition of Involution by Dexamethasone Is Systemic 
and Affects All Glands of the Animals 
A  similar series of experiments was performed with dexa- 
methasone-, prolactin-, or as a control BSA-release pellets 
implanted into the fourth mammary gland after 5 d of lac- 
tation. The pups were removed and the glands were ana- 
lyzed 3 d later. Dexamethasone efficiently inhibited a col- 
lapse of lobulo-alveolar structures (Fig. 2 a) and the alveoli 
were enlarged and filled with milk whereas BSA had no 
inhibitory effect (Fig. 2 c). At the same time no degrada- 
tion  of chromosomal DNA could be detected  by in situ 
terminal transferase assays in dexamethasone-release pel- 
let implanted glands (Fig. 2 b). In the case of BSA many 
epithelial cell nuclei stained positive indicating that DNA 
fragmentation has occurred (Fig. 2 d). The effect of dexa- 
methasone was found to be systemic and to affect not only 
the gland implanted with the dexamethasone-release pel- 
let but  all the  mammary glands  of the  animal (data  not 
shown). Prolactin was found to be ineffective in prevent- 
ing  mammary  gland  involution  and  DNA  degradation 
when released from a pellet (Fig. 2, e and f). A  combina- 
tion of dexamethasone and prolactin was equally efficient 
in preventing involution as dexamethasone alone (Fig. 2, g 
and h). 
Taking advantage of the systemic effect exerted by dexa- 
methasone additional molecular parameters of involution 
and PCD were investigated. Total DNA was isolated from 
the gland and analyzed by gel electrophoresis. As can be 
seen in Fig. 3 an oligonucleosomal fragmentation of DNA 
typical for cells  undergoing  programmed cell death  was 
apparent in control glands implanted with a BSA-contain- 
ing pellet (lane 2) or a prolactin-containing pellet (lane 4) 
while no DNA fragmentation was apparent in the DNA 
Figure 2.  Dexamethasone but not prolactin prevents involution  and PCD. At lactation mammary glands were implanted with dexa- 
methasone-release pellets (a and b), BSA-release pellets (c and d), prolactin-release  pellets  (e and f), or dexamethasone/prolactin- 
release pellets (g and h). The pups were removed and the glands were analyzed 3 d later. Shown are hematoxylin/eosin  stained sections 
(a, c, e, and g) next to the pellet (P). The right panels (b, d, f, and h) show the result of a terminal transferase assay derived from serial 
sections of the same areas of the glands. The pellets (P) are visible at the left end of each panel. Bar, 100 Ixm. 
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inhibited by dexamethasone but 
not by prolactin. Mammary glands 
were implanted at lactation with 
BSA-release  pellets  (lane  2), 
dexamethasone-release  pellets 
(lane  3),  prolactin-release  pel- 
lets  (lane 4), or dexamethasone/ 
prolactin-release  pellets (lane 5). 
The pups were removed and the 
glands  were  analyzed  3  days 
later.  Shown is  the  DNA  after 
electrophoretic  separation  on a 
1.5%  agarose  gel.  A  100-bp 
DNA ladder is shown in lane 1. 
prepared  from glands implanted with release  pellets con- 
taining dexamethasone or dexamethasone/prolactin (lanes 
3 and 5, respectively). 
We  have  previously shown  a  striking  induction  of nu- 
clear  PKA  activity  in  the  mammary  gland  in  the  early 
phase  of involution  that  precedes  and  probably contrib- 
utes  to  an  elevated  level  of fos  and ]un  gene  expression 
and  AP-1  DNA  binding  activity in  the  involuting  gland. 
The level of PKA activity was determined  in nuclear ex- 
tracts prepared from mammary glands 2 and 3 d  after im- 
planting  a  dexamethasone-,  prolactin-,  dexamethasone/ 
prolactin-, or control BSA-containing pellet. As can be seen 
from Fig. 4 a none of the release pellets was capable to in- 
hibit an activation of nuclear PKA activity in these glands 
(lanes 4-11)  and the levels were similar to the levels regu- 
larly measured during normal involution (lanes 2 and 3). It 
was of interest to investigate whether fos and ]un gene ex- 
pression and AP-1 DNA binding activity, which are puta- 
tive  targets  of PKA in  these  cells,  would  be  elevated  in 
pellet-implanted  glands.  DNA binding activity was deter- 
mined  by bandshift  analysis.  AP-1  was  found  to  be  ele- 
vated in all pellet-implanted  glands and the level of activ- 
ity was found to be comparable to the level determined at 
day three of normal involution (Fig. 4  b).  We also deter- 
mined  the  DNA binding  activity of the  mammary gland 
factor MGF that regularly decreases during normal involu- 
tion (Schmitt-Ney et al.,  1992).  In animals implanted with 
dexamethasone  or  prolactin-release  pellets  we  found  a 
high level of MGF DNA binding activity and the level was 
significantly lower in mammary glands of control animals 
or in animals  implanted  with  a  BSA control pellet  (data 
not shown). 
We also determined the level of expression of milk pro- 
tein genes, and the putative AP-l-dependent sulfated gly- 
coprotein gene (SGP-2), fos and ]un genes and the metal- 
loprotease stromelysin-1 gene, both, in animals implanted 
with  dexamethasone-release  pellets  or BSA-release  con- 
trol pellets. The expression of WAP, a major milk protein, 
is maintained  at  a  high level for 4  d  in mammary glands 
implanted  with  a  dexamethasone-release  pellet  and  the 
level drops to a very low level in control animals implanted 
with a BSA-release pellet (Fig. 5). During the same period 
the level of expression of SGP-2 was increased to a lower 
level in glands implanted with dexamethasone-release pel- 
lets  as  compared  to glands  of control  animals  implanted 
with BSA-release pellets.  Similar increases were observed 
in the expression  of ]unB  and ]unD  in hormone-exposed 
and in control glands (Fig. 5). The level of c-fos measured 
in  glands  that  were  exposed  to  dexamethasone  was  ele- 
vated  as  compared  to  control  glands  (Fig.  5).  The  pro- 
moter  of the fos  gene  is  complex  and  contains  multiple 
control  elements  that  confer  positive  responsiveness  to- 
wards elevated cAMP and PKA (Fisch et al., 1989; Boutillier 
et  al.,  1992)  as  well  as  negative  responsiveness  towards 
AP-1 (Sch6nthal et al.,  1989). c-jun that is expressed dur- 
ing normal involution and is at least in part autoregulated 
by AP-1 (Angel et al., 1988) was induced to a lower level 
in glands implanted with dexamethasone-release pellets as 
compared to glands of control animals implanted with BSA- 
release pellets (Fig. 5). Most strikingly, we found a strong 
Figure 4.  PKA and AP-1 are 
induced  in  pellet  implanted 
mammary glands.  Hormone- 
release  pellets  containing 
dexamethasone,  prolactin, 
dexamethasone/prolactin,  or 
BSA were implanted  at lac- 
tation and the pups were re- 
moved.  Nuclear  extracts 
were  prepared  from  unim- 
planted  glands  at  lactation 
and after 1, 2, or 3 d of invo- 
lution or from glands 2 or 3 d 
after  implantation  with  hor- 
mone-release pellets  as indi- 
cated, a shows the result of a 
PKA  activity.  Phosphory- 
lated  (P)  and  non-phos- 
phorylated  peptide  (non-P) 
were separated electrophoretically. AP-1 DNA binding activity 
was determined by bandshift analysis  (b).  Only the area of the 
gel containing the protein/DNA complex is shown. 
Figure 5.  Dexamethasone in- 
hibits  the expression of AP- 
1--dependent  genes.  Hor- 
mone-release pellets contain- 
ing dexamethasone (lanes 2- 
4) or BSA (lanes 6-8) were 
implanted  at  lactation  and 
pups  were  removed.  RNA 
was extracted from glands at 
lactation  (lanes  1  and  5)  or 
from pellet-implanted  glands 
after 2, 3, or 4 d and analyzed 
for the  expression  of WAP, 
SGP-2,  c-fos, c-]un, ]unB, 
]unD, stromelysin-1,  TIMP-1, 
or  actin  by  Northern  blot 
analysis as indicated. 
The Journal of Cell Biology,  Volume 131, 1995  1100 inhibition of AP-l-dependent stromelysin-1 gene expres- 
sion  in  animals  implanted  with  dexamethasone-release 
pellets but not in control animals suggesting that the AP-1 
complex  that  accumulates  in  these  dexamethasone- 
exposed glands is in a  non-functional conformation. The 
expression of TIMP-1, a functional antagonist of metallo- 
proteases,  was  only moderately affected by dexametha- 
sone and actin expression was used as a control. 
Discussion 
We demonstrate that glucocorticoid hormones inhibit in- 
volution and PCD. Deoxycorticosterone acetate maintains 
the alveolar morphology and inhibits nuclear DNA frag- 
mentation in the vicinity of the pellet but not distant to the 
pellet indicating that the response of the mammary tissue 
towards glucocorticoids is local and does not involve a sys- 
temic signal. Our results suggest that glucocorticoids that 
are important regulators of milk protein synthesis may in 
addition  act  as  survival  factors  in  mammary  epithelial 
cells.  An  activity  of additional  survival  factors  such  as 
EGF or EGF-like peptides or insulin-like peptides on epi- 
thelial cells in culture was recently demonstrated (Merlo 
et al., 1995) and further studies will be required to evalu- 
ate whether glucocorticoids affect the  activity of any of 
these  hormones in vivo. Interestingly, progesterone was 
similarly shown to inhibit involution and PCD in the vicin- 
ity of the pellet. This points to an inhibitory mechanism 
that is shared by different steroid receptors. Earlier studies 
have shown that daily injections of high doses of glucocor- 
ticoids inhibited mammary involution in vivo and in vitro 
(Johnson and Meites, 1958; Ossowksi et al., 1979). Prolac- 
tin had a similar effect but only when injected into the ani- 
mal and not in mammary explants cultured in vitro (Os- 
sowski et al., 1979). We show that prolactin fails to inhibit 
involution and PCD when administered locally. This sup- 
ports the hypothesis postulated by Ossowski et al.  (1979) 
that prolactin exerts its action indirectly by sensitizing the 
animal towards other hormones. 
In contrast to deoxycorticosterone acetate, dexametha- 
sone affects all mammary glands equally. This can proba- 
bly be explained by the high stability of dexamethasone 
that leads to elevated hormone levels in the serum. In fact, 
the endogenous glucocorticoid hormone levels were strongly 
reduced  in  animals  implanted  with  a  dexamethasone- 
release pellet (<3 nMol per liter 4  d  after implantation, 
data not shown), probably as a result of a suppression of 
the adrenal glands in these animals. Furthermore, a similar 
inhibition of involution was observed when a dexametha- 
sone-release pellet was implanted under the skin distant 
from the mammary gland (data not shown). Several mark- 
ers have been described previously that are upregulated 
during involution. Among them are SGP-2, TGF-131, and 
stromelysin-1 (Strange et al., 1992), plasminogen activator 
(Ossowski et al., 1979), PKA, c-fos, c-jun, junB, and junD 
(Marti et al.,  1994a).  Our results demonstrate that rela- 
tively early events such as the induction of PKA and AP-1 
DNA binding activity are not significantly altered by dexa- 
methasone. However, the expression of SGP-2, c-]un, and 
stromelysin-1 mRNA is inhibited in the presence of dexa- 
methasone (Fig. 5). Interestingly, these genes contain AP-1 
response elements in their promoter regions and are po- 
tential target genes of AP-1 (Angel et al.,  1988; McDon- 
nell et al., 1990; Kerr et al., 1992; Wong et al., 1993, 1994; 
F.  Martin,  personal  communication).  TGF-131  was  also 
shown to be an AP-l-regulated gene (Kim et al., 1990). A 
partial inhibition of TGF-IM mRNA induction was found 
in the mammary gland in the presence of dexamethasone 
(data not shown).  Several steroid hormone receptors in- 
cluding those for glucocorticoids and progesterone have 
been shown to functionally interfere with AP-1 (Jonat et 
al.,  1990;  Lucibello et  al.,  1990;  Yang-Yen  et  al.,  1990; 
Shemshedini et al., 1991). In the case of the glucocorticoid- 
mediated AP-1 repression it was shown that the glucocor- 
ticoid receptor affects AP-1  function without disturbing 
the  DNA  binding  capacity of AP-1  (Jonat  et  al.,  1989; 
KOnig et al.,  1992). It is very likely that the inhibition of 
stromelysin-1, c-jun, SGP-2, and TGF-131 gene expression 
is at least in part due to a functional inhibition of AP-1 in 
animals implanted with glucocorticoid-release pellets. Our 
results demonstrate that this inhibition is paralleled by an 
inhibition of involution and PCD in the mammary gland. 
Interestingly, we found elevated c-los mRNA levels in 
the presence of dexamethasone that could also be a conse- 
quence of glucocorticoid receptor-mediated AP-1 inacti- 
vation. The los promoter is complex and it was shown to 
confer positive responsiveness to various growth factors 
(Greenberg and Ziff, 1984; Kruijer et al., 1984; Miiller et 
al.,  1984) and also to cAMP and PKA (Fisch et al.,  1989; 
Boutillier et al., 1992). Furthermore, c-fos expression was 
shown to be regulated by AP-1 through a negative feed- 
back  mechanism  (Sch6nthal  et  al.,  1989;  Gauthier-Rou- 
vi6re et al., 1992). It is likely that the elevated PKA activ- 
ity contributes to c-fos expression during involution. The 
relatively higher  level  of expression in  dexamethasone- 
exposed glands as compared to control glands could be a 
consequence of an absence of AP-l-mediated down-regu- 
lation. This independently suggests that AP-1 function is 
impaired in glands exposed to dexamethasone. 
The observed inhibition of stromelysin-1 expression could 
affect involution very significantly as it was demonstrated 
that the degradation of the basement membrane by metal- 
loproteases is an important step of mammary gland invo- 
lution (Talhouk et al., 1992) and promotes apoptosis of ep- 
ithelial cells in culture (Boudreau et al., 1995). A  function 
of AP-1 would therefore be to contribute to the basement 
membrane degradation  during involution by stimulating 
the expression of metalloproteases such as stromelysin-1. 
This hypothesis was recently further substantiated by re- 
suits based on in situ hybridizations where the expression 
of stromelysin-1 and SGP-2 was shown to take place in ep- 
ithelial cells (Z. Feng, K. Guo, and R. Friis, personal com- 
munication), c-Fos and JunD, which are the major compo- 
nents of AP-1 during involution (Marti et al., 1994a) were 
recently shown to be expressed in the mammary epithe- 
lium during involution as measured by immunohistochem- 
ical  studies  (Marti  et  al.,  1995).  Furthermore,  we  have 
shown that an activation of PKA during lactation by the 
means of cholera toxin-release pellets leads to an activa- 
tion of AP-1 and to PCD of epithelial cells in the vicinity of 
the pellet (Z. Feng, A. Marti, and R. Jaggi, manuscript in 
preparation). 
Independent studies have shown increased levels of p53 
expression during mammary gland involution (Strange et 
Feng et al. Inhibition of  Apoptosis by Steroid Hormones  1101 al., 1992; Marti et al., 1995). We measured a partial inhibi- 
tion of p53 expression at the mRNA level in dexametha- 
sone-exposed glands as compared to control glands (data 
not shown). A  putative role of p53 was discussed during 
involution  of  the  mouse  prostate,  another  hormone- 
dependent  gland.  Whereas  Berges  et  al.  (1993)  claimed 
that prostate involution occurs normally in p53 knock out 
mice, Colombel et al. (1995) demonstrated that apoptosis 
and involution are delayed in the absence of p53. Prelimi- 
nary studies in p53 knock out mice suggest that involution 
is delayed but not impaired in mammary  glands of these 
mice (Feng, Z., R. Friis, and A. Clarke, unpublished obser- 
vation). Cell death induced by serum-free medium in sev- 
eral  mammary  epithelial  cell  lines  in  culture  was  also 
shown to be independent of p53 (Merlo et al., 1995). These 
observations would suggest that PCD of mammary epithe- 
lial cells can occur in the absence of p53. 
In summary,  our data suggest  that several steroid hor- 
mones are able to maintain the morphology of the lactat- 
ing mammary  gland  and  to inhibit mammary  involution 
and PCD  of mammary epithelial cells.  To date,  the only 
function that is  known to be  shared  by different  steroid 
hormone receptors is their capacity to functionally impair 
transcription factor AP-1.  Based  on the observation that 
the activation of PKA and the expression of genes that are 
regulated via PKA are not affected  by steroid hormones 
implies  that  the  steroid  hormone-mediated  effects  are 
downstream of these initial events and most probably af- 
fect AP-1 at the level of its biological activity. The fact that 
the inhibition of AP-1  function is paralleled by an inhibi- 
tion of involution and PCD  of mammary  epithelial cells 
suggests  that AP-1  exerts  an  important  function during 
mammary gland involution. Further studies are  required 
to elucidate in detail the molecular consequences of AP-1 
regulated  genes  on  the  actual  process  of PCD  in  dying 
mammary epithelial cells. 
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